Ladislav Anděra
Impact in
- Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Cell death mechanisms and regulation 38
- RNA Interference and Gene Delivery 6
- Ubiquitin and proteasome pathways 5
- Mitochondrial Function and Pathology 4
-
- NF-κB Signaling Pathways 10
- Co-authors
- Jiřı́ Neužil (14 shared papers)Alexander Pintzas (6 shared papers)Bohdan Wasylyk (2 shared papers)Lenka Doubravská (3 shared papers)Konstantinos G. Drosopoulos (2 shared papers)C. Weber (5 shared papers)Pavel Klener (17 shared papers)Michal Koc (7 shared papers)
- Journals
- APOPTOSIS (6 papers)FEBS Letters (5 papers)Blood (4 papers)Clinical Cancer Research (3 papers)Blood Advances (2 papers)
- Partner nations
- CzechiaRussiaUnited States
In The Last Decade
Ladislav Anděra
80 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 118
- Biochemistry 227
- Oncology 720
- Cancer Research 392
- Molecular Biology 1.8k
- Biotechnology 147
Countries citing papers authored by Ladislav Anděra
This map shows the geographic impact of Ladislav Anděra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ladislav Anděra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ladislav Anděra more than expected).
Fields of papers citing papers by Ladislav Anděra
This network shows the impact of papers produced by Ladislav Anděra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ladislav Anděra. The network helps show where Ladislav Anděra may publish in the future.
Co-authors
The 25 scholars most cited alongside Ladislav Anděra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. | 2002 | 172 |
| 2 | 2007 | 163 | |
| 3 | 2007 | 160 | |
| 4 | 2003 | 154 | |
| 5 | 1996 | 151 | |
| 6 | 2011 | 124 | |
| 7 | 2001 | 106 | |
| 8 | 2002 | 94 | |
| 9 | 2018 | 85 | |
| 10 | 2001 | 78 | |
| 11 | 2015 | 76 | |
| 12 | 2005 | 72 | |
| 13 | 2019 | 64 | |
| 14 | 2013 | 56 | |
| 15 | 1997 | 56 | |
| 16 | 2004 | 50 | |
| 17 | 2006 | 50 | |
| 18 | 2018 | 44 | |
| 19 | 2010 | 40 | |
| 20 | 2005 | 40 |
About Ladislav Anděra
Ladislav Anděra is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Biotechnology, having authored 81 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (38 papers), NF-κB Signaling Pathways (10 papers), Cancer-related Molecular Pathways (10 papers), RNA Interference and Gene Delivery (6 papers), Cancer Research and Treatments (5 papers), Ubiquitin and proteasome pathways (5 papers), Telomeres, Telomerase, and Senescence (5 papers) and Mitochondrial Function and Pathology (4 papers). The work is most often cited by research in Biochemistry (227 citations), Oncology (720 citations), Cancer Research (392 citations), Molecular Biology (1.8k citations) and Biotechnology (147 citations). Ladislav Anděra has collaborated with scholars based in Czechia, Russia and United States. Frequent co-authors include Jiřı́ Neužil, Alexander Pintzas, Bohdan Wasylyk, Lenka Doubravská, Konstantinos G. Drosopoulos, C. Weber, Pavel Klener, Michal Koc, Eftychia Oikonomou and Nina Gellert. Their work appears in journals such as APOPTOSIS, FEBS Letters, Blood, Clinical Cancer Research and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.